Personalisation is the future of cancer care
Unique journey
Related Posts
AlzeCure’s NeuroRestore ACD856 to be presented at AD/PD 2025
Preclinical data highlights potential in treating Alzheimer’s disease AlzeCure Pharma AB announced that its abstract on NeuroRestore ACD856 has been accepted for presentation at the […]
Migraine takes the spotlight at European Parliament
EMHA calls for its inclusion in EU neurological health strategy The European Migraine and Headache Alliance (EMHA) has urged EU policymakers to include migraine in […]
